Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | STK012 |
Trade Name | |
Synonyms | STK 012|STK-012 |
Drug Descriptions |
STK012 is a PEGylated IL-2 mutein selective to CD25 and CD122, which potentially leads to increased anti-tumor immune response (Cancer Res 2021;81(13_Suppl):Abstract nr 1744). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C185286 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + STK012 | Pembrolizumab STK012 | 0 | 1 |
STK012 | STK012 | 0 | 1 |